CoapTech, Inc.
StreetZero Signal 70
About CoapTech, Inc.
CoapTech, Inc. is a Baltimore-based medical device company developing the PUMA System, a patented ultrasound-based technology for minimally invasive placement of gastrostomy feeding tubes and other procedures in hollow organs. The PUMA-G system received FDA 510(k) clearance and supports point-of-care ultrasound magnet alignment. Founded in 2016, the company has been recognized as a Maryland Tech Council Life Science Company of the Year finalist and Medtech Innovator Best-in-Class Startup.
LATEST FUNDINGSeries B
$970K
Announced 2026-11-16
TOTAL RAISED$24.4M
IN THE NEWS
- ๐ CoapTech Raises New Funding Round Led by Good Growth Capital - BioHealth Innovation
- ๐ CoapTech Raises $7M in Series B Funding Led by Hunniwellย - Hunniwell Lake Ventures - Home
- ๐ CoapTech 2026 Company Profile: Valuation, Funding & Investors | PitchBook
- ๐ CoapTech Raises New Funding Round Led by Good Growth Capital โ MedTech Innovator
- ๐ CoapTech - 2026 Company Profile, Team, Funding & Competitors - Tracxn
EMPLOYEESโ
FOUNDED2016
HQBaltimore, MD, United States
Industry
Biotechnology
Tags
Medical DeviceBiotechnologyUltrasoundSeries B
Investors
Key highlights
- Raised initial Series B close in May 2025 led by Good Growth Capital with university-affiliated investors.
- Closed $7M Series B tranche in 2024 led by Hunniwell Lake Ventures for PUMA-G commercialization.
- Total funding reported between $16.5M and $24.4M across 10โ11 rounds from 15+ investors.
- PUMA-G system FDA-cleared via 510(k) pathway for ultrasound-guided feeding tube placement.
- Multiple awards including Maryland Incubator Company of the Year and Medtech Innovator Best-in-Class.
Ask StreetZero about CoapTech, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account